๐ Great discussion at the Access Consortium Town Hall at #DIAGlobal.
Together with regulators from Australia, Canada, Singapore and Switzerland, we're advancing regulatory cooperation to support faster patient access to medicines.
๐ brnw.ch/21x3qoI
MHRAgovuk
5,638 posts
We want our social channels to be safe spaces for healthy, open and insightful discussion. Please read our community guidelines here bit.ly/47gazWC
- Patients, families and carers: We want to hear from you. Help shape the future of rare disease therapies in the UK by responding to our consultation before 30 July 2026. brnw.ch/21x3pS0
- ๐ฃ Moments ago we announced a new liaison programme with the FDA to enhance day-to-day collaboration, support scientific exchange and enable faster, more coordinated approaches to emerging regulatory challenges and decisions. brnw.ch/21x3mWq
- MHRAgovuk repostedOur third panel of the day, โRegulation reinvented: Accelerating approvals and enhancing patient safety,โ begins with representatives from @unibirmingham, @edqm_news, @karolinskainst and @CorriXR, chaired by Mr. Lawrence Tallon, Chief Executive, @MHRAgovuk. #PrixGalien
- ๐ Congratulations to Dr Nicola Rose, our Executive Director of Science and Research, on being appointed an OBE in the 2026 King's Birthday Honours for services to science and public health. Read more ๐ brnw.ch/21x3jmQ
- ๐๏ธ We are looking to appoint a Clinical Pharmacologist to the Review Panel. To find out more about this role and to apply, visit ๐
- ๐ข Thousands of people across the UK have contributed to the conversation about the future regulation of AI in healthcare. Today, we've published findings from the National AI Commission's call for evidence, research and engagement activities. โก๏ธ
- ๐ What questions do patients and the public have about AI in healthcare? Over 900 people registered for our Ask Me Anything event, submitting 180 questions on safety, transparency, accountability, human oversight and trust. Watch the recording ๐
- 9 in 10 medicines fail during development โ often due to challenges predicting safety early on. A new sandbox will explore how AI can spot side effects earlier. ๐
- Traditional development pathways weren't designed for many rare diseases. We're consulting on a new framework that could support earlier access to promising therapies while maintaining patient safety. Have your say before 30 July 2026 - ๐ brnw.ch/21x3735
- ๐๏ธ We are looking to appoint a Chair to the Advisory Board on the Registration of Homeopathic Products (ABRHP). To find out more about this role and to apply, visit ๐
- โ ๏ธ Two people have been arrested after MHRA officers uncovered a facility suspected of manufacturing and supplying unlicensed weight loss medicines. ~ 12,000 doses were seized in the operation, supported by Northamptonshire Police. More information ๐ brnw.ch/21x2W9x
- ๐ฃ โ๏ธ Donโt let the heatwave affect your medicines: 3 key tips from the MHRA Hot weather can affect how your body responds to medicines โ and how well they work. As temperatures rise, hereโs advice from our experts on how to stay safe ๐brnw.ch/21x2Puy
















